Portal hypertension is a common and serious complication of chronic liver disease and gives rise to many of the features and complications associated with cirrhosis including variceal haemorrhage and ascites. The management of these complications has become one of the commonest and most important aspects of hepatology and as the prevalence of cirrhosis increases treatment of liver failure and haemorrhage related to portal hypertension seems of even greater importance in clinical practice.
Transjugular intrahepatic portosystemic stent shunts (TIPSS) is a highly effective and relatively noninvasive way of correcting portal hypertension. Not only have the potential indications for TIPSS increased since its introduction into clinical practice in 1989 but also the technique itself has changed with new technical aspects being introduced, especially new stents. The introduction of the new polytetrafluoroethylene covered stents appears to be highly effective in reducing shunt dysfunction and represents an important development.
TIPSS was originally introduced for, and has been most applied in, the management of variceal haemorrhage related to portal hypertension. It is clearly highly effective in controlling acute bleeding and is also associated with a rebleeding rate superior to endoscopic techniques. While its place in the control of acute variceal bleeding has been little studied by the way of randomized clinical trials, it is now widely used as rescue therapy following failure of endoscopic treatment. The value of TIPSS in preventing rebleeding has been the focus of numerous randomized controlled trials (RCTs). The value of TIPSS in the treatment of bleeding gastric and ectopic varices has been widely reported but little studied in RCTs. Again, it appears effective, but its value in comparison with endoscopic and other interventional radiological techniques is still unclear. Refractory ascites is a common clinical problem and can undoubtedly be improved by treating the portal hypertension. The place
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of TIPSS compared with repeated paracentesis has been studied in a number of RCTs but the position remains unclear with different results appearing from different trials. Limited experience of TIPSS in the management and prevention of hepatorenal syndrome exists, gain with different results being reported in different series.
A further use of TIPSS has been in the management of patients with Budd Chiari syndrome. As a result of the relative rarity of this condition, however, reports are of uncontrolled series and RCTs are not available. TIPSS has also been advocated in a variety of other complications of cirrhosis, such as portal hypertensive gastropathy and hepatopulmonary syndrome.
This review in depth on TIPSS summarizes each of the areas outlined above by authors with great experience with this technique and we are very grateful to all the contributors for their efforts in sharing their knowledge in writing each of the art reviews about this important and sometimes controversial subject. We hope this issue will stimulate further debate and hopefully clinical trials in this area.
